Expression Profiling the Temperature-Dependent Amphibian Response to Infection by Batrachochytrium dendrobatidis by Ribas, Laia et al.
Expression Profiling the Temperature-Dependent
Amphibian Response to Infection by Batrachochytrium
dendrobatidis
Laia Ribas
1, Ming-Shi Li
2, Benjamin J. Doddington
1, Jacques Robert
3, Judith A. Seidel
1, J. Simon Kroll
2,
Lyle B. Zimmerman
4, Nicholas C. Grassly
1, Trenton W. J. Garner
5, Matthew C. Fisher
1*
1Department of Infectious Disease Epidemiology, Imperial College London, United Kingdom, 2Department of Paediatrics, Imperial College London, London, United
Kingdom, 3University of Rochester Medical Centre, Rochester, New York, United States of America, 4Developmental Biology, National Institute for Medical Research,
London, United Kingdom, 5Institute of Zoology, Regent’s Park, London, United Kingdom
Abstract
Amphibians are experiencing a panzootic of unprecedented proportions caused by the emergence of Batrachochytrium
dendrobatidis (Bd). However, all species are not equally at risk of infection, and risk is further modified by environmental
variables, specifically temperature. In order to understand how, and when, hosts mount a response to Bd we analysed
infection dynamics and patterns of gene expression in the model amphibian species Silurana (Xenopus) tropicalis.
Mathematical modelling of infection dynamics demonstrate the existence of a temperature-dependent protective response
that is largely independent of the intrinsic growth-rate of Bd. Using temporal expression-profiling by microarrays and qRT-
PCR, we characterise this response in the main amphibian lymphoid tissue, the spleen. We demonstrate that clearance of Bd
at the host-optimal temperature is not clearly associated with an adaptive immune response, but rather is correlated with
the induction of components of host innate immunity including the expression of genes that are associated with the
production of the antimicrobial skin peptide preprocareulein (PPCP) as well as inflammatory responses. We find that
adaptive immunity appears to be lacking at host-optimal temperatures. This suggests that either Bd does not stimulate, or
suppresses, adaptive immunity, or that trade-offs exist between innate and adaptive limbs of the amphibian immune
system. At cold temperatures, S. tropicalis loses the ability to mount a PPCP-based innate response, and instead manifests a
more pronounced inflammatory reaction that is characterised by the production of proteases and higher pathogen
burdens. This study demonstrates the temperature-dependency of the amphibian response to infection by Bd and indicates
the influence that changing climates may exert on the ectothermic host response to pathogens.
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Introduction
Amphibians are experiencing a panzootic of unprecedented
proportions caused by the emergence of Batrachochytrium dendroba-
tidis (Bd) [1,2,3,4]. While anthropogenic spread of Bd appears to be
driving the global distribution of the pathogen [5], disease and
declines are modulated by a complex interaction between
environment, host and pathogen-specific factors [6,7]. Research
has identified temperature as a key factor in predicting the spatial
occurrence of Bd-related declines [8,9], and longer-term climate
trends appear to drive these patterns of disease by amplifying the
growth of Bd at its thermal optimum [6,7]. However, this model
ignores the potential contribution of host immunity. While it is
known that amphibian antimicrobial peptides (AMPs) correlate
with species survival against Bd [10,11], it is not known if
amphibians mount a specific response against Bd, or to what extent
any host response is temperature-dependent. Amphibians are
ectotherms, and seasonal temperature variability exerts strong
direct effects on their immune system [12]. As a consequence, the
susceptibility of amphibians to pathogens is expected to vary
between seasons. Across longer temporal scales, global warming is
negatively affecting survival of even widespread habitat-generalists
such as the common toad Bufo bufo [13]. Therefore, the outcome of
infection by Bd is likely to be exacerbated by synergies between
short-term temperature-dependent effects on the immunocompe-
tence of animals and longer-term physiological stressors.
Here, we describe the use of mathematical models and post-
genomic technologies to identify the pathogen-associated gene
expression profiles that a model amphibian species, Silurana
(formerly Xenopus) tropicalis, exhibits in response to infection by
Bd at different temperatures. We focus on defining the temporal
dynamics of infection at two infection time-points, days 7 and 42,
and at two temperatures; these temperatures were chosen to reflect
the ‘tropical’ environmental norm for S. tropicalis,2 6 uC, and a
lower, non-optimal ‘temperate’ temperature, 18uC. By using these
two temperatures, we shifted the animals’ environment towards
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(Figure 1) [14]. In order to quantify the importance of host
immunity and Bd growth-rate at these two different temperatures,
we profiled the prevalence and intensity of Bd burdens in frogs
over a 42-day infectious time course. By using a simple
mathematical model, we estimated the contributions of host-
response and Bd-growth to the observed infectious outcomes. In
tandem, we investigated variation in the host response by profiling
time and temperature-dependent global gene expression profiles in
the main lymphopoietic tissues in frogs, the spleen by using
microarrays and qRT-PCR transcriptomic strategies. Finally, we
compared our data with the recent publication of the S. tropicalis
transcriptome-response to Bd exposure at cool (18uC) temperatures
[15].
Results and Discussion
Bd Infection Dynamics
Quantitative Bd-specific PCR shows that the prevalence and
intensity of infection peaked in animals at each temperature
between days 7 and 26 (Figure 1A & C). This suggested that the
frogs were mounting an anti-Bd response in both groups, as
animals were exposed to high infections (,10
6 zoospores per
procedure) throughout the course of the experiment; in the
absence of a host response levels of infection should climb
throughout the lifetime of the experiment. There was a higher
prevalence and intensity of infection in iCT (infected Cold
Temperature group) compared to iWT (infected Warm Temper-
ature group) frogs throughout the experiment (Figure 1). Fitting a
mathematical model of the infection process (Figure 1A) showed
that animals in the iWT treatment had approximately a third of
the chance of infection per procedure compared with those in the
iCT treatment (biWT=0.170 and biCT=0.451) and, once infected,
iWT animals recovered almost five times as fast (ciWT=0.071 and
ciCT=0.015). After accounting for the greater Bd growth rate at
the cooler temperatures, the fit of our model was consistent with
iWT frogs clearing zoospores approximately twice as fast as iCT
frogs (c iWT=1.322 and c iCT=0.646). Modelling prevalence
assuming an identical host response in iWT animals as in iCT
animals does not fit the observed data well (Figure 1). This finding
Figure 1. Experimental infection and model outputs. A. Observed prevalence data for iCT animals (blue circles) and modelled prevalence data
(blue line, RSS (residual sum of squares) =0.112), and observed prevalence data for iWT animals (red circles) and modelled prevalence data (solid red
line, RSS=1.99). Dotted orange line shows modelled iWT prevalence data where an identical host response to iCT animals has been assumed. g
means the gap between modelled prevalence in iWT with and without differing host response due to temperature. Modelling prevalence without
taking into account a differing host response does not fit the observed data well (RSS=1611). B. Third order polynomial fitted to measurements of
temperature against daily exponential growth rate of Bd in culture from [14] (y=-0.00008639x
3 + 0.002612x
2 – 0.001124x – 0.0004419). Blue circle
indicates Bd growth rate at the temperature of iCT animals, and red circle indicates Bd growth rate at the temperature of iWT animals. C. The intensity
of infection measured by qPCR as zoospore genomic equivalents.
doi:10.1371/journal.pone.0008408.g001
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to Bd than do iCT frogs.
Overview of Patterns of Differential Gene-Expression
To identify the molecular basis of the host response to Bd
infection, we used microarrays to profile gene expression in the
cold and warm infected cohorts at days 7 and 42 of infection (see
Figure S1 for the experimental design). We focused on the spleen
which, in the absence of lymph nodes, is the major lymphoid
organ in S. tropicalis. This profiling revealed that there was a
robust infection-specific aspect to the global induction of gene
expression following exposure to Bd, and this response was both
temperature- and time-dependent. From a total of 10,878 probes,
following normalization to the controls, 434 genes for the iCT
and 492 genes for the iWT groups were differentially regulated
throughout the experiment. On day 7, frogs had received two
exposures to Bd with the result that the ratio of significantly up-
regulated:down-regulated genes (the ‘‘up:down ratio’’) in iCT
frogs was 133:95, compared to a ratio in iWT frogs of 96:88. By
day 42, after twelve successive exposures to Bd, iCT frogs showed
an up:down ratio of 105:81 compared to 71:121 for iWT frogs.
Within these differentially expressed groups of genes, iWT frogs
expressed significantly (Student t-test: p,0.01) higher numbers of
genes with a fold change .30 (2.3%) and 2.5–1.5 (74%) relative
to iCT frogs where fold change ranged between .30 (1.83%) and
2.5–1.5 (56.5%). There was little overlap in expression profiles
between these two time-points within groups, even when the
stringency of the statistical analysis was reduced to p,0.05; here
iCT frogs shared 3.30% of genes between days 7 and 42 and iWT
frogs shared 2.62%. This finding shows that both infected groups
are changing their expression profiles during the intervening 35
day period to a large degree. Temperature-independent genes
that were shared between iCT and iWT groups represented
4.76% of the total expression profiles. Differentially regulated
genes (.1.5 fold and p,0.01) in Bd infected groups compared
against controls are summarized in Table S1. Principal
component analysis (PCA) of gene expression in the spleen
(Figure 2B) showed that early (day 7) iCT frogs contributed the
most diverse patterns of gene-expression of any group, as well as
showing the highest prevalence and intensities of infection
(Figure 1). These animals were in ‘double jeopardy’ because
they faced both a non-optimal temperature [16,17] and infection
by Bd that is growing close to, or at, its environmental optimum
[14,18].
Figure 2. Microarray results in spleen of S. tropicalis Bd infected. A. Expression of the top 50 genes obtained from microarrays with known or
putative immune-function as shown by two-way gene clustering and clustering analysis (GeneSpring Software). The colour scale shows the fold
changes above normalised controls. B. Principal Component Analysis (PCA) showing that S. tropicalis frogs held at cold temperatures (iCT) have the
most diverse transcriptional profile during the first stage (7 days) of infection. Axis: X=PCA Component 1 (24.99% variance); Y=PCA Component 2
(18.12% variance); Z=PCA Component 3 (14.95% variance).
doi:10.1371/journal.pone.0008408.g002
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Strikingly, the most highly expressed gene in the spleen of iWT
frogs 7 days after Bd exposure was the AMP preprocaerulein type
III precursor (PPCP; Figure 2, 3). Microarray analysis showed that
this gene was found to be expressed 59 fold change above controls
in spleen (Table S1, Figure 3A). The decapeptide caerulein is a
principal constituent of the skin secretion of a variety of amphibian
species [19,20,21] and is the most potent AMP to be secreted by S.
tropicalis, with a demonstrated antimicrobial activity against 22
microbial species including Gram-positive bacteria and the fungus
Candida albicans [22]. The strong up regulation of the differential
PPCP expression observed by the microarrays was further
validated by qRT-PCR individually for the spleens of all 52
experimental frogs (WT and CT groups; Figure 3B). Interestingly,
expression of PPCP was not detected in spleen, or at low levels, in
the control group, and there was no significant induction of this
gene in any of the CT groups. qRT-PCR showed that PPCP
expression levels were up to 71-fold upregulated in day 7 iWT
frogs, confirming our microarray results. These results suggest that
PPCP is specifically upregulated by S. tropicalis in response to Bd
infection, and that induction only occurred at temperatures that
are optimal for the host. Production of PPCP-protein has not
Figure 3. Microarray validation by quantitative RT-PCR for each of the 52 experimental frogs using spleen RNA. For qRT-PCR analysis,
samples were analysed in triplicates for each individual (control and infected). A. Microarray validation by qRT-PCR amplification for a subset of 10
genes with known or suspected roles in immunity. Black bars = microarray data (pooled samples); White bars = qRT-PCR validation data (individual
samples). Data is expressed by log2 Relative Quantification versus the control group.. B. Further transcriptomic analysis by qRT-PCR of the expression
of PPCP and trypsinogen 2 genes individually tested for all frogs (n=52). Data is expressed by log2 Relative Quantification versus the control group
(iWT7/cWT7, iWT42/cWT42, iCT7/cCT7 and iCT42/cCT42) 6 Standard Error. * Indicates significance by Student t-test (p,0.05) compared to the control
group at each time point.
doi:10.1371/journal.pone.0008408.g003
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glands [23], however further analysis using qRT-PCR of skin-
tissue showed no clear evidence of PPCP RNA production (Ribas,
unpub. obs.). Furthermore, the recent publication by Rosenblum et
al. [15] of the transcriptomic response in the liver and skin of
infected S. tropicalis by Bd at 18uC also did not find any expression
of AMPs in either of these tissues. Together, these findings raise
the interesting and potentially important hypothesis that the spleen
could be involved in manufacturing and the subsequent trafficking
of this peptide following Bd infection as a first response of the
innate system, and that this only occurs early on in infection, and
at host-optimal temperatures. However, further work is needed to
investigate this hypothesis, including an investigation of the
temporal nature of AMP secretion and it’s efficacy in the skin
against Bd, following infection.
Within the iWT cohort, levels of expression of PPCP had
reduced to background by day 42 (Figure 3B) showing a strong
temporal dependency in the expression of this gene. The
production of AMPs is induced following exposure to various
pathogens in other amphibian species, such as Rana esculenta
[24,25]. Pathogen-specific induction of AMPs has been demon-
strated for this species, where it was shown that it only synthesises
AMPs when microbes (bacteria or fungi) are present [25]. The
reduction in PPCP production over time that we observe is
possibly correlated with the recurrent nature of our infection
regime; frogs were challenged every 4 days with over 10
6
zoospores and such high levels of infectious assault are likely to
exhaust the capacity of these frogs to synthesise, traffic and
discharge, PPCP [26]. In addition to PPCP, a second AMP, the
Cytastin C precursor peptide, was found to be upregulated by 2.6
fold (Table S1, Figure 2A, 3a) increasing the evidence of the key
role of AMPs in protection of amphibians from pathogens [27].
However, as for the PPCP results described above, it is unclear
whether increased expression of this protein in the spleen
represents de novo synthesis of this AMP, or rather its presence in
the spleen is a consequence of the system-wide trafficking of this
precursor peptide.
It is estimated that X. tropicalis genome has around 28,000 genes,
therefore the Operon v1.0 S. tropicalis microarray that we use here
represents a subset of around 40% of these genes and lacks probes
for many of the immune genes involved in the anti-pathogen
response. Nevertheless, cluster analysis identified a number of
genes with homology to vertebrate genes with known roles in
immunity. We identified 50 genes with known immune-associated
function, and demonstrate the upregulation of several other genes
with suspected roles in vertebrate innate immunity (Figure 2A).
Notably, genes encoding cell-surface receptors were upregulated
over the first stages of infection, indicating that pathways involved
in innate-pathogen recognition are rapidly activated (Figure 2A,
3A). For example, tumour necrosis factor associated factor (TRAF,
1.5 fold) which interacts directly or indirectly with members of the
TNFR superfamily [28], fucose binding lectin (2.3 fold) and leptin
receptor (2.1 fold) were rapidly induced after two exposures of Bd.
Subsequently, a down regulation of these pathogen-recognition
genes were observed at the end of experiment (fucose binding
lectin, -36.7 fold). Activation of other inflammatory markers,
guanylate binding protein interferon inducible (1,44 fold),
calcineurin interleukin (IL) 2 inducible (1,33 fold) and trypsinogen
genes, were also observed (Figure 2, Table S1). Expression of these
trypsinogen genes were significantly increased after 42 days of
exposure, although this effect was not as strong as in animals
infected at cold temperatures (Figure 2 and 3B, see below). Genes
responsible for hemopoietic stem cell maintenance such as
VENTX2 (2.6 fold) and hematopoietic SH2 protein adaptor (1.5
to 26 fold) were also increased at 7 days of infection, suggesting
that hematopoietic cell development in the spleen is upregulated as
a result of infection [29].
In marked contrast to the upregulation of genes involved in
innate immunity, the expression of several genes with roles in the
generation of an adaptive immune response were downregulated
in the spleen over the experiment. Such genes include the B-cell
translocation gene (21.88 fold, day 7) and the cutaneous T-cell
lymphoma associated antigen (21.69 fold, day 42). The
complement factor B, an element of the complement system
which bridges the innate and adaptive immunity with a critical
importance for the generation of a potent humoral response [30]
was also inhibited throughout the infection in iWT frogs (21.63
fold, day 7 and 23.33 fold, day 42; Table S1, Figure 2A). Our
results are in concordance with the findings of Rosenblum et al.
[15] where five complement pathway genes were shown to
decrease their expression in S. tropicalis liver after Bd infection [15].
In this study, these authors raise the hypothesis that a lack of
evidence for an adaptive immune response to Bd both in liver and
skin tissues is suggestive of a more complex, perhaps inhibitive,
effect of Bd on the immune system. Although more needs to be
done to understand the role of specific-immunity in combating Bd
infection, our experimental results suggest a central role of the
amphibian spleen as an effector of the innate immune system, and
support the conclusion that there is little evidence for an active
adaptive immune-reaction.
Differentially-Expressed Genes in ‘Cold Infected’ Frogs
Microarray data showed that expression of the AMP PPCP did
not occur in iCT frogs (Figure 2A). In order to confirm the lack of
the expression of this skin peptide in this group, we individually
analysed the expression of PPCP by qRT-PCR. Expression of this
gene amongst individual iCT frogs was significantly lower than
that found among the iWT group (Figure 3B), validating the
microarray findings (Figure 2A). Principal component analysis of
gene expression in the spleen (Figure 2B) showed that in particular,
the iCT 7 day group had the most divergent transcriptional
pattern; this was in concordance with the mathematical model
where frogs subjected to non-optimal temperatures presented the
highest prevalence and intensities of infection. Among the top 50
highly up-regulated genes in the spleen of Bd infection in the cold
group, seven genes corresponded to serine protease transcripts
(trypsinogens, chymotrypsin, zymogen and elastases; Figure 2A).
Serine protease proteins are involved in several photolytic
pathways but are also recognised effectors of the innate immune
system and are associated with generalised inflammation [31,32].
Our analysis showed a large increase in levels of expression from
day 7 to day 42 for these genes (19 fold change; Figure 3B) in iCT
animals and a similar, but less pronounced effect, was seen in the
iWT frogs (Figure 3B). Here, we speculate that iCT frogs are
attempting to compensate for their lack of PPCP-production by
upregulating the production of serine proteases as a secondary,
inflammatory, innate immune response. The production of serine
proteases are pro-inflammatory markers as they represent an
increase in mast-cell activity and degranulation [33,34]; this may
well provide a protective role as our prevalence data and
modelling show that even the iCT frogs are able to control their
Bd infections, albeit to a lesser degree than is seen in the iWT
groups.
In mammals, inflammatory immune reactions are catalysed by
the cross-linking of mast-cells with IgE, and this constitutes the
major host-response to mucosal gastrointestinal nematodes [35].
The inverse relationship seen here between PPCP and protease
production in animals subjected to cold temperatures suggests that
Amphibian Anti-Bd Immunity
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tropicalis innate immune response, i.e. that inflammatory responses
and secreted AMPs may be mutually inhibitory. If this is the case,
then the reduction of AMP-activity seen in iCT and late-stage
iWT animals may be the major factor allowing an upregulation of
these inflammatory cell-responses.
Wider Conclusions
We have infected the African Pipid frog S. tropicalis at two
temperatures and profiled the group prevalence and intensities of
infection over 42 days. This has shown that both frogs held at
‘optimal’ temperatures (iWT; 26uC) and those held at ‘non-
optimal’ temperatures (iCT; 18uC) are able to survive very high,
repeated, doses of Bd. Profiling infection using qPCR has shown
that both groups of frogs manifest an early peak of infection
followed by a reduction in prevalence; this suggests that both
groups of frogs are clearing infection however that the frogs held at
‘optimal’ temperatures clear their infections faster. We then asked
the question ‘does this effect occur due to either the increased
growth of Bd at lower temperatures or to more effective host-
responses at warmer temperatures?’ We use a simple mathematical
model parameterised on measured Bd growth rates at different
temperatures to address this question. Our findings show that,
while the Bd growth-rates can explain some of the difference
between the prevalence of infection between iCT and iWT groups
of frogs, the rate of zoospore clearance needs to be far higher for
the iWT animals in order to explain our data, even when taking
into account the decrease in Bd growth-rates at 26uC (shown as the
differences between the ‘blue’ and ‘red’ spots in Figure 1B). This
difference in zoospore clearance between the iWT and iCT frogs is
shown as the difference g in Figure 1A. As the rate of zoospore
clearance is analogous to the effectivity of the host response, these
findings suggest that frogs held at ‘optimal’ 26uC temperatures are
mounting a response that is able to clear Bd infections.
We then identified the basis of this host response in ‘optimal’
iWT compared to ‘non-optimal’ iCT frogs by profiling the
changes in the host transcriptome for early (day 7) and late (day
42) infections in the major amphibian lymphoid tissue, the spleen.
Because we were interested in identifying ecologically-relevant
effects, we chose to house animals in groups rather than singly.
While this prevents our analysis from looking at individual-level
effects (our transcriptional-level responses are for the experimental
groups pooled between tanks), our results are ecologically relevant
as S. tropicalis are colonial in nature and cohabit ponds. Further, a
pooling strategy enabled us to extract enough rRNA from these
frogs small spleens for direct Cy3/Cy5 labelling; this enabled us to
avoid pre-amplifying the RNA using PCR, a process which
introduces unknown biases in gene-expression. Recent studies by
Kendzidorski et al. [36] have shown that most genes in expression
studies are not adversely affected by pooling strategies and that the
increase in sample-sizes (52 in this study) outweigh the loss of
power in ascertaining individual-level-responses.
Our analyses of the S. tropicalis spleen-transcriptome showed
extensive differences between all of our combinations of
experimental groups. Because the frogs spleens were pooled
between tanks, we removed tank-level effects. Therefore, the
residual changes in gene-expression are attributable to our three
major variables, ‘infection’, ‘time’ and ‘temperature’; all of which
contribute to major changes in expression levels in the S. tropicalis
spleen. Despite the complex patterns that we found, we were able
to isolate three major signals that discriminated between infected
and uninfected animals. These were (1) strong upregulation of
innate immune AMP-effectors at host optimal temperatures early
in infection, (2) ablation of this response in frogs housed at 18uC
and (3) a serine-protease proinflammatory response in both
optimal and non-optimally-housed frogs.
One of the great conundrums surrounding the emergence of Bd
has been its extraordinarily wide host-range in over 350 species,
the greatest seen for any vertebrate pathogen to date ([37]; www.
spatialepidemiology.net/bd-maps). It has long been suspected that
this wide distribution may result from the ability of the pathogen to
manipulate and subvert host-immunity or to avoid detection.
Recent data by Rosenblum et al. [15] have provided important
experimental evidence for this hypothesis by showing that several
genes that are associated with immune functions, such as toll-like
pathogen receptors and complement-pathway genes, are down-
regulated in infected S. tropicalis. Our data also support this
hypothesis by showing that putative markers of B-cell, T-cell and
complement factors are downregulated in the spleens of animals
that have been infected at host-optimal 26uC temperatures.
Unfortunately, a full comparison between ours, and Rosenblum
et al.’s studies is not possible due to the limited gene-set (40%) that
are represented on the Operon AROS microarrays that we have
used, preventing effective cross-comparisons. However, recent
unpublished data targeting a wider panel of adaptive immune-
markers in the S. tropicalis liver by qPCR confirm our general
findings by showing that these markers are all downregulated in
infected frogs at host-optimal temperatures (Seidel, Ribas &
Fisher, unpub. data). Taken together, these observations stemming
from independent studies by different research groups are broadly
concordant in their conclusion that there is a generalised down
regulation in markers of adaptive immunity in S. tropicalis following
infection by Bd.
Work on another class of eukaryotic pathogens exhibiting wide
host ranges, the helminths, has shown that these parasites exhibit
widespread subversion of host immunity; strategies include
skewing the host response towards a tolerogenic TH2 responses,
interference with antigen-processing and modulation of antigen-
presenting cells [35]. Interestingly, the final two processes are
thought to be modulated by nematode homologues of mammalian
cystatins, which function to maintain mammalian dendritic cells in
their immature state in order to downregulate antigen presentation
[38]. In this study we found that the cystastin C precursor peptide
was upregulated in iWT frogs when Bd burdens were highest (at
day 7), suggesting that a modulation of host immunity by this
mechanism may be occurring. Searching the Bd genome for close
homologues of vertebrate proteins with known roles in immune
evasion and down-regulation of host immune responses should
provide a fruitful approach to identifying whether these specific
virulence factors occur. If found, such virulence factors would
provide evidence that a long co-evolutionary history has occurred
between Bd and its Pipid hosts [39,40]; this is predicted by the
‘Out of Africa’ hypothesis advocated by Weldon et al. accounting
for the global spread of this pathogen owing to the international
trade in Pipid species [41].
It is not clear from our study why markers of adaptive immunity
are downregulated in iWT frogs. However, down regulation of S.
tropicalis’ adaptive immunity may be a consequence of the route of
infection (cutaneous) and the primary immunity (AMP-mediated and
inflammatory innate immunity). The clearest finding from our study
was that the most over-expressed transcript (up to x70 fold) was
associated with an innate-effector AMP. The various arms of the
vertebrate immune response are interdependent, and the upregula-
tion of one arm has extensive effects on the expression of other
immune modes; the TH1/TH2 inhibitory dicotomy is a well known
example of this effect. It may be that over-expression of AMPs has a
dampening effect on other limbs of the amphibian immune-system,
resulting in under-expression of adaptive-immune effectors. Howev-
Amphibian Anti-Bd Immunity
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herecanbecaptured bysimple‘innateversusadaptive’models,anda
systematic network analysis of S. tropicalis interactomes on an
individual basis is required to dissect these interactions [42]. Recently
reported preliminary results demonstrating the development of high-
titer antibodies to Bd in Xenopus laevis injected with the heat-killed
pathogen and subsequently exposed to live zoospores [43], suggest
that Pipids are able to make anti-Bd antibodies. In this case, then the
route of infection is likely to be important in determining what sort of
host response is manifested. Importantly, our data show that, owing
to the lack of a strong adaptive immune response but high innate
response, it is unlikely that S. tropicalis can be primed to respond to
subsequent challenges of Bd by using acutaneous method of infection;
w es u g g e s tt h a ti tw i l ln o tb ee a s yt od e v e l o pv a c c in e sa g a i n s tBd and it
is unlikely that wild populations will acquire a natural immunity to
the pathogen.
Mathematical modelling of the dynamics of infection in our
experimental treatments has shown that frogs maintained below
their temperature optimum reduce the generation of a successful
anti-Bd response, resulting in higher infectious burdens. Analysis of
the iCT versus control CT and iWT animals suggests that this may
be due to a lack of AMP production; there was no expression of
PPCP in the iCT frogs. This may explain why Rosenblum et al.
found no evidence of AMP upregulation in their whole-genome
arrays as, in their experimental design, all frogs were housed at
18uC; these conditions correspond to our iCT group which was not
found to express markers of AMP activity. These findings are likely
to be ecologically relevant as it has been shown that, in the field,
immunity is temperature-dependent and forced by seasonal
patterns. For example seasonal surveys of adult Red spotted newts
(Notophthalmus viridescens) by Raffelet al[12] showed a springlag effect
in lymphocyte levels and strong seasonal acclimatization of
lymphocyte, neutrophil and eosinophil levels in the autumn. A
body of work now exists on the prerequisite of a successful AMP-
response to manifest resistance to chytridiomycosis at the species
level [18,44,45]. Taken together, these studies suggest that factors
that influence AMP production are likely to change whether
populations/species are refractory to chytridiomycosis, or whether
they succumb. It is important to note that there is an apparent
association between declines of species and altitude, with popula-
tions at higher altitudes suffering greater losses and extinction rates
[6,46]. There is now a clear need for such field-based immunolog-
ical studies among infected populations to investigate the impor-
tance of the host response in the epidemiological triad (host, Bd and
the environment). Such studies will quantify the influence that
changing climates areable to exert on the ectothermic hostresponse
to this devastating emerging pathogen.
Materials and Methods
Ethics Statement
All experiments involving amphibians were conducted under
Licence from the British Home Office following the Animals
(Scientific Procedures) Act of 1986. Welfare of the amphibians
followed the principles of the 3R’s; reduction, refinement and
replacement and were overseen by a named Veterinarian as well
as Animal Care and Welfare Officers. All experiments were
preceded by full ethical review by the Imperial College Ethical
Review Committee and the British Home Office, and were fully
approved by these two organisations.
Silurana tropicalis Infection and Temperature Model
52 adult female frogs of the species S. tropicalis (average weight
12.6 g) were reared in 8 water tanks (3–4 frogs per tank) in
temperature-controlled rooms stabilised at 18uC, cold temperature
group (CT) or 26uC warm temperature group (WT); Figure S1.
Frogs were infected with Bd by individual exposures to 10
6 Bd
zoospores in a 100 ml bath for 3 hours (these groups are
designated iCT or iWT). Bd strain IA042 passage 10 was isolated
from infected Alytes obstetricans in the Pyrenees, Spain and cultured
in ThGL liquid media; zoospore inocula were standardised by
counting motile zoospores using a haemocytometer. Isolate IA042
is known to have high virulence from previous experiments [39].
Exposures were repeated twice a week for 7 or 42 days (iCT7,
iCT42, iWT7, iWT42). Control animals were similarly treated
with regular transfer to an experimental bath, but were exposed to
ThGL medium as a sham-infection (groups CT7, CT42, WT7,
WT42). Animal welfare was checked daily while feeding and equal
amounts of food given to all groups. We observed no sign of illness
beyond skin-sloughing early on in the experimental regime, and no
mortality occurred. Throughout the experiment, dermal swabs
were taken (days 0, 7, 26 and 42) from each animal and infection
monitored by a Bd-specific TaqMan Assay (Boyle et al. 2004)
(Figure S1). In order to ensure that we were working with a Bd–
free colony, frogs were swabbed and tested prior to starting the
experiment and were all found to be negative. At days 7 and 42,
animals were euthanized by ten-minute exposure to an overdose of
MS-222 before the spleen from each animal was rapidly dissected
on ice and placed into RNAlater (Qiagen), then kept at 280uC
until further transcriptomic analysis (microarray & qRT-PCR).
Bd Dynamics and Mathematic Modelling
The prevalence and intensities of infection were estimated using
a qPCR Taqman assay [47]. Briefly, Bd DNA was extracted from
swabs and a TaqMan-probe assay used in an Applied Biosystems
7300 Sequence Detection System. Samples were prepared in
duplicate with negative controls, and a standard curve was used to
quantify the number of Bd zoospore genomic equivalents. The
observed prevalence of infection are shown in Figure 1A.
In order to dissect the relative importance of host immunity
versus Bd growth-rates, a mathematical model of the experiment
was created assuming a constant rate of clearance of infection, and
infection only at infection procedures. The model splits the
experimental animals into three categories: Susceptible (S),
Infected (I) and Recovered (R). All animals begin in the
Susceptible category, from which they move into the Infected
category at bS animals per infection procedure (which occurred
bi-weekly). Infected animals then recover into the Recovered
category at rate cI (such that the time spent infected is
exponentially distributed.). The equations for the model are given
below.
dS
dt
~{bS  at infection procedure and 0 otherwise ð1Þ
dI
dt
~{cIzbS  at infection procedure and {cI otherwise ð2Þ
dR
dt
~cI ð3Þ
where b is the rate of infection per procedure, c is the recovery rate
once infected, and * indicates a change at a single time point.
This model makes two major assumptions: that the chance of
infection via transmission from an infected animal is negligible
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once an animal recovers it now has either, or a combination of,
such a low chance of infection that it will now no longer be
infected, or such a fast rate of recovery that if infected it will clear
zoospores fast enough that it will show up as negative when tested
for infection – i.e. once recovered, animals will stay in the
Recovered category. Transmission is assumed to be negligible
compared to infection by procedure as the highest intensity of
infection reported from any animal was 15.12 zoospore genomic
equivalents, whereas each procedure exposed the animals to 10
6
zoospores, an amount several magnitudes greater than any
possible exposure from other animals. To test whether reinfection
can be assumed to be negligible, a model was created in which
animals in the Recovered compartment were allowed to become
reinfected, with different infection and recovery rates to that of
newly infected animals. Fitting this model to the prevalence data
gave a greatly reduced rate of infection and increased rate of
recovery for re-infected recovered animals, supporting the
assumption.
The average infected lifespan (T ) for both iCT (infected 18uC)
and iWT (infected 26uC) animals was calculated from the infection
model as the inverse of c. In order to discern whether differences
in infected lifespan between the two models can be explained
entirely by differences in Bd growth-rate, or whether a differing
host response at each temperature was required, the host response
necessary at each temperature in order to return the zoospore
count to 0.1 genome-equivalents (the amount above which
infection is indicated) at the end of the average infected lifespan
was then calculated. This was done by assuming Bd growth within
the host is exponential, with a rate determined by two opposing
factors: the intrinsic exponential growth of Bd at that temperature
(r), and the rate of zoospore clearing by the host (c). To determine r
the daily exponential growth rate of Bd in culture was calculated
for each temperature [48] and then fitted to a third order
polynomial equation (Figure 1B) from which r was calculated for
both experimental temperatures. As so little is known about the
immune response of S. tropicalis to fungal infections, the simplest
form possible for the rate of clearing zoospores has been assumed,
with c remaining constant and acting from the moment of
infection. Provided that the exponential growth rate of Bd in
culture is comparable to the uninhibited growth rate of Bd on the
host, and that further infection procedures have no effect on the
number of zoospores infecting the host, the required rate of
clearing can then be calculated using the equation Ze
(r2c)T=0.1,
where Z is the number of zoospores initially infecting the host, and
has been assumed to be directly proportional to the rate of
infection and the number of zoospores used per procedure. The
values of c for both warm and cold experiments were then
compared. Mathematical models were fitted to infection dynamics
using Berkeley Madonna 8.3.14.
Microarray Hybridization and Transcriptomic Analysis
RNA samples from all spleen tissues were individually prepared
(n=52) using Qiagen RNeasy Mini Kit Columns (Qiagen) and
further treated with DNaseI (Invitrogen). RNA quality and
quantity was assessed using Bioanalyzer 2100 with RNA 6000
Nano LabChip Kit (Agilent Technologies) and NanoDrop 1000
Spectrophotometer (NanoDrop Technologies). To achieve enough
RNA for direct Cy5 labelling without resorting to PCR pre-
amplification, RNA spleens from 2 or 3 animals were pooled to
give 3 pools of spleen RNA samples for each group of animals (see
Figure S1) following published studies [36]. Samples were pooled
between tanks but within experimental groups to remove tank-
level effects. Sample (4 mg) of each RNA-pool were labelled using
SuperScript III cDNA synthesis kit, oligo d(T) primer (Invitrogen)
and Cy5-dCTP (GE Healthcare/Amersham). The resulting
products were purified using a QIAquick cleaning kit (Qiagen).
In parallel, a universal reference RNA sample was created from
the spleen of an outgroup of animals (n=4), which was further
amplified to achieve large quantities using Amino Allyl Messa-
geAmp
TM II aRNA Amplification (Ambion). The resulting aRNA
was labelled using a Cy3 mono-Reactive Dye Pack (GE
Healthcare/Amersham). This Cy3-labelled aRNA was served as
an universal reference (see below) to provide consistent slide-to-
slide and experiment-to-experiment comparability. The principle
and reliability of universal reference system using pooled RNA or
amplified RNA were originally described [49,50].
A total of 24 Xenopus tropicalis V1.0 AROS DNA microarray
slides were obtained from Operon Biotechnologies (www.operon.
com) and previously described [51]. The array design is available
at ArrayExpress (www.ebi.ac.uk) under accession number A-
MEXP-1446. Slide hybridization and washing steps were
performed according to manufacture’s protocol using buffers
provided with the kit (Operon Biotechnologies). Each array slide
was co-hybridized with one of the Cy5 labelled experimental
samples and Cy3 labelled aRNA (universal reference). The
resulting slides were scanned using a GenePix 4000B (Axon)
microarray scanner and the scanned images were analysed with
GenePix Pro6.0 (Axon). Statistical analysis was carried out using
Genespring GX 7.3 (Agilent). Background-subtracted spot inten-
sities resulting from hybridisation of Cy5-labeled cDNA derived
from experimental RNA (signal channel) were divided by the
intensity of the signal derived from Cy3-labeled aRNA (control
channel). Log-transformed ratios were normalized by applying the
intensity-dependent data analysis technique LOWESS, using 20%
of the data for smoothing. Only genes not marked absent by
GenePix Pro analysis were included. If the value for the reference
channel was less than 10 then a value of 10 was used instead. Data
arising from the three pooled biological replicates were combined
as follows:
For each gene, the normalized log-transformed ratio arising
from samples harvested from the infection group kept at 26uC for
7 days (iWT7) was re-normalized to the median value, as was that
arising from uninfected group kept at 26uC for 7 days (cWT7).
These were combined to give a ratio iWT7/cWT7. Likewise, the
ratio were also generated for iWT42/cWT42, iCT7/cCT7 and
iCT42/cCT42, representing experimental groups conditioned at
26uC for 7 days, at 18uC for 7 days and 18uC for 42 days,
respectively. Differentially expressed genes were identified as genes
showing more than 1.5-fold up- or down-regulation (p#0.01) using
a Student t-test in GeneSpring. Fully annotated microarray data
have been deposited under ArrayExpress accession number E-
MEXP-1936. Expression values are shown in Table S1.
Microarray Validation
Microarray-based gene expression patterns were confirmed for
a subset of 10 genes (Figure 3A, Table S2) with known or
suspected roles in immunity, by using qRT-PCR. In order to
maximise the power of our data, individual analyses were run for
each of the experimental frogs. A total of 52 individual spleen
RNA samples, 12 for control (CT, WT) and 14 for infected
animals (iCT, iWT) for each treatment group (7 and 42 days),
were reverse-transcribed using SuperScript III and oligo d(T)
(Invitrogen). The resulting cDNA were used as templates in qRT-
PCR run in Applied Biosystem 7100 as following: Cycle 1; 50uC
2 min., Cycle 2; 95uC 10 min., Cycle 3; 95uC 15 sec., 60uC 1 min
for 40 times. Samples were run as triplicates, with water and RNA
as negative controls. All expression values were normalised against
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gene expression levels for these qRT-PCR results were analysed
using the 2
2DDCT method [52] showing log2 Relative Quantifica-
tion versus the control (iWT7/cWT7, iWT42/cWT42, iCT7/
cCT7 and iCT42/cCT42) 6 Standard Error.
Further gene expression analysis was performed in order to
assess the reliability of the transcriptomics results, for two target
genes of interest; the skin peptide PPCP and the serine-protease
trypsinogen 2. These two genes were individually tested by qRT-
PCR from the spleen RNA all 52 experimental frogs prior to
pooling. Statistical analyses of the Relative Quantification results
were completed using the Student t-test in the R-Software
Package.
The subset of validated genes were(Table S2):musclespecificgene
(Xt_10001800), trypsinogen 2 (Xt_10000537), T-cell (Xt_10005209),
CD82 antigen (Xt_10002930), TRAF (Xt_10007227), Preprocaer-
ulein type III precursor (Xt_10003079), epithelial membrane protein
2 (Xt_10006495), cystatin C precursor (Xt_10001311), BCL2/
adenovirus (Xt_10007462) and protein EST EC2BBA27CH07
(Xt_10007462).
Supporting Information
Figure S1 Schematic of the experimental design. Frogs were
infected with Bd by individual exposures to 106 Bd zoospores in a
100 ml bath for 3 hours (iCT or iWT). These exposures were
repeated twice a week for 7 or 42 days (iCT7, iCT42, iWT7,
iWT42). Control animals were similarly treated with regular
transfer to an experimental bath, but exposed to ThGL medium as
a sham-infection (CT7, CT42, WT7, WT42). Throughout the
experiment, dermal swabs were collected from each animal and
infection monitored by Bd-specific TaqMan Assay (*). For
transcriptomic analysis RNA was extracted individually from
spleen tissues. To achieve enough RNA samples for direct Cy5
labelling without amplification for microarray hybridization,
spleen RNA from 2 or 3 animals were pooled to give 3 pools of
spleen RNA samples for each animal group. In parallel, a
universal reference RNA sample was created from spleen of an
out-group animals (n=4), and was largely amplified aRNA. 3 and
4 microarray slides were used for each experimental group for
control and infected treatment respectively (a total of 24
microarray slides). Microarray validation and other transcriptomic
analysis were performed by qRT-PCR individually for each
animal group of the experiment.
Found at: doi:10.1371/journal.pone.0008408.s001 (0.55 MB TIF)
Table S1 Expression values of the microarray results in spleen of
animals Bd infected after 7 or 42 days. For statistical analysis, see
the Materials and Methods section of the manuscript. Fully
annotated microarray data have been deposited under ArrayEx-
press with accession number E-MEXP-1936.
Found at: doi:10.1371/journal.pone.0008408.s002 (0.18 MB
XLS)
Table S2 Primer information for the genes used in validating the
microarray analysis.
Found at: doi:10.1371/journal.pone.0008408.s003 (0.05 MB
PDF)
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